Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population

12 Jan 2017

Abstract excerpt

OBJECTIVE: To assess the clinical utility of cell-free DNA (cfDNA)-based screening for aneuploidies offered through primary obstetrical care providers to a general pregnancy population. METHODS: Patient educational materials were developed and validated and providers were trained. Serum was collected for reflexive testing of cfDNA failures. Providers and patients were surveyed concerning knowledge, decision...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28079901
DOI: 10.1038/gim.2016.194

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy populationPMID 28079901Read ↗

Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 casesSemantic proximity Read ↗

Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA)Semantic proximity Read ↗

Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysisSemantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessmentSemantic proximity Read ↗

Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variantsSemantic proximity Read ↗

Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomesSemantic proximity Read ↗

Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-AnalysisSemantic proximity Read ↗

Cell-Free DNA Analysis for Noninvasive Examination of TrisomySemantic proximity Read ↗

Non-invasive prenatal testing of fetal chromosomal aneuploidies: validation and clinical performance of the veracity testSemantic proximity Read ↗

Genetic Counselors’ Experience with Cell‐Free Fetal DNA Testing as a Prenatal Screening Option for AneuploidySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.